← Back to Patent Explorer
US4816478A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of acquired immunodeficiency syndrome

Assignee: DMK Pharmaceuticals Corp
•
Filing: 1987-08-24
•
Granted: 1989-03-28
•
Expires: 2007-08-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A treatment of Acquired Immunodeficiency Syndrome (AIDS) and AIDS Related Complex (ARC) with therapeutically effective amounts of semisynthetic derivatives of dihydroartemesinin and synthetic compounds with a sesquiterpene structure.

Inventors

  • 👤 Carl R. Thornfeldt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 21:36
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 34 words
A method of the treatment of a human subject suffering from AIDS or ARC comprising systemically administering to said subject a composition containing an artelinic acid in an amount therapeutically effective in said treatment.
Claim 2
Independent Claim 34 words
A method of the treatment of a human subject suffering from AIDS or ARC comprising systemically administering to said subject a composition containing an artelinic acid in an amount therapeutically effective in said treatment.
Claim 3
Independent Claim 46 words
A method for the treatment of a human subject suffering from AIDS or ARC comprising systemically administering to said subject a composition containing a member selected from the group consisting of artemether, artesunate, propyl carbonate dihydroartemisinin, and dihydroartemisinin, in an amount therapeutically effective in said treatment.
Claim 4
Independent Claim 46 words
A method for the treatment of a human subject suffering from AIDS or ARC comprising systemically administering to said subject a composition containing a member selected from the group consisting of artemether, artesunate, propyl carbonate dihydroartemisinin, and dihydroartemisinin, in an amount therapeutically effective in said treatment.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-27 1992-09-26 1993-03-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-27 1996-09-26 1997-03-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-27 2000-09-26 2001-03-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag